Showing results (21-30 of 260) with videos related to
Sort By:
Pageof 26
Expert Review of Clinical Pharmacology|October 24, 2023
The expert clinical pharmacological advice program for tailoring on real-time antimicrobial therapies with emerging TDM candidates in special populations: how the ugly duckling turned into a swanMilo Gatti, Federico PeaFrontiers in Antibiotics|January 16, 2025
Pharmacokinetic/pharmacodynamic issues for optimizing treatment with beta-lactams of Gram-negative infections in critically ill orthotopic liver transplant recipients: a comprehensive reviewMilo Gatti, Federico PeaCurrent Opinion in Infectious Diseases|July 15, 2021
Continuous versus intermittent infusion of antibiotics in Gram-negative multidrug-resistant infectionsMilo Gatti, Federico PeaClinical Pharmacokinetics|June 14, 2021
Antimicrobial Dose Reduction in Continuous Renal Replacement Therapy: Myth or Real Need? A Practical Approach for Guiding Dose Optimization of Novel AntibioticsMilo Gatti, Federico PeaExpert Review of Anti-Infective Therapy|April 14, 2025
Critical reappraisal of current issues for improving the proper clinical use of the incoming beta-lactam/beta-lactamase inhibitor combinations of tomorrowMilo Gatti, Federico PeaInfection and Drug Resistance|March 23, 2026
Real-World Evidence and Multidrug Resistant Infections: How Can We Leverage RWE to Improve Patient Outcome with the Novel Beta-Lactam and Beta-Lactam/Beta-Lactamase Inhibitor CombinationsMilo Gatti, Federico PeaThe Journal of Antimicrobial Chemotherapy|January 6, 2018
Overview of antifungal dosing in invasive candidiasisFederico Pea, Russell E LewisJournal of Thrombosis and Thrombolysis|September 12, 2022
The pharmacokinetics of recombinant FXIII (catridecacog) from the MENTORTM2 trial to a real-world study: a head-to-head comparisonSamantha Pasca, Cojutti PierGiorgio, Federico Pea, et al.Clinical Pharmacokinetics|September 24, 2005
Antimicrobial therapy in critically ill patients: a review of pathophysiological conditions responsible for altered disposition and pharmacokinetic variabilityFederico Pea, Pierluigi Viale, Mario FurlanutExpert Review of Anti-Infective Therapy|June 13, 2015
Clinical pharmacological approach for balancing the use of daptomycin and linezolid in comparison with that of vancomycin in the treatment of MRSA-related infectionsFederico Pea, Nicola Petrosillo, Javier GarauPageof 26